POWERFUL RESULTS WITH STRONTIUM89

Proof of powerful pain relief

Unfortunately, nearly half of people with bone mets live in pain. Strontium89 is here to help. In study after study, Strontium89 has been shown to provide significant bone pain relief.

79%

PAIN RELIEF

In its pivotal trial, up to 79% of study participants had
REDUCED PAIN with Strontium89.*

Freedom from bone pain is possible

2x

PAIN FREE at
3 MONTHS

Twice as many study participants treated with Strontium89 were
PAIN FREE at 3 months compared with placebo.

*In a multi-center Canadian placebo-controlled trial of 126 participants who had persistent pain after receiving external radiation therapy, after adding a single injection of Strontium89, 71% (n=42) of participants had a reduction in pain and analgesic scores compared with 61% (n=44) of participants taking placebo at 1 month, 79% (n=38) of participants had a reduction in pain and analgesic scores compared with 57% (n=35) of participants taking placebo at 2 months, and 61% (n=33) of participants had a reduction in pain and analgesic scores compared with 56% (n=34) of participants taking placebo at 3 months.

In the same study,  after adding a single injection of Strontium89, 14.3% of participants (6/42)  had a reduction in pain and analgesic scores to zero, compared with 6.8%  of participants (3/44) taking placebo at 1 month, 13.2% of participants (5/38) had a reduction in pain and analgesic scores to zero compared with 8.6% of participants (3/35) taking placebo at 2 months, and 15.2% of participants (5/33) had a reduction in pain score and analgesic score to zero compared with 5.9% of participants (2/34) taking placebo at 3 months.

Fewer new pain sites

59%

Strontium89

At 3 months, no new bone mets pain sites* were experienced in more participants receiving Strontium89.

Vs.

34%

Placebo

Although Strontium89 can be taken with other types of treatments, these study participants achieved results without any increase in other pain medications.

The information contained in this section is intended for US healthcare professionals only.